| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | ANGIE ELISA Kit; ANGIE2 ELISA Kit; B cell attracting chemokine 1 ELISA Kit; B cell-attracting chemokine 1 ELISA Kit; B lymphocyte chemoattractant ELISA Kit; B-cell chemoattractant ELISA Kit; B-cell-attracting chemokine 1 ELISA Kit; B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1) ELISA Kit; BCA-1 ELISA Kit; BLC ELISA Kit; BLR1L ELISA Kit; C-X-C motif chemokine 13 ELISA Kit; Chemokine (C-X-C motif) ligand 13 ELISA Kit; Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) ELISA Kit; Chemokine; CXC motif; ligand 13 ELISA Kit; CXC chemokine BLC ELISA Kit; CXCL13 ELISA Kit; CXL13_HUMAN ELISA Kit; SCYB13 ELISA Kit; Small inducible cytokine B subfamily (Cys-X-Cys motif); member 13 (B-cell chemoattractant) ELISA Kit; Small inducible cytokine B13 ELISA Kit; Small inducible cytokine subfamily B; member 13 ELISA Kit; Small-inducible cytokine B13 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
B-Lymphocyte Chemoattractant 1 (CXCL13) is a biological molecule commonly studied in immunology research. It is often studied in the context of chemokine-driven cell trafficking and inflammatory communication.
UniProt: O43927
Biological context
Researchers often monitor B-Lymphocyte Chemoattractant 1 in serum, plasma, and tissue homogenates to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in B-Lymphocyte Chemoattractant 1 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, B-Lymphocyte Chemoattractant 1 may also appear under names such as ANGIE and ANGIE2. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that B-Lymphocyte Chemoattractant 1 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythaematosus with disease activity
Y Zhang,Authorea,2020
CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
Zeng YL.et al,Springerplus.,2016
Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression
Tuumlrkoglu R et al,Med Princ Pract,2014